Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

An Affect Management Intervention for Juvenile Offenders

This study has been completed.
Sponsor:
Information provided by:
Rhode Island Hospital
ClinicalTrials.gov Identifier:
NCT00748800
First received: September 5, 2008
Last updated: February 5, 2009
Last verified: February 2009
  Purpose

Adolescents are at risk for HIV because of sexual and drug behavior initiated during this developmental period. Adolescents in the juvenile justice system are at increased risk for HIV due to higher rates of substance use and psychopathology than their non-offending peers. Juvenile justice youth may therefore also be less likely to benefit from frequently used skills based interventions. It appears that emotional lability, frequently found in this population, disrupts skills learned. This project will implement and evaluate an affect management HIV prevention intervention for adolescents in a juvenile drug court program. Affect management and general health promotion interventions will be compared to determine which intervention best reduces risk behavior among adolescents in the drug court.


Condition Intervention Phase
HIV Infections
Behavioral: Affect Management
Behavioral: General Health Promotion
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: An Affect Management Intervention for Juvenile Offenders

Resource links provided by NLM:


Further study details as provided by Rhode Island Hospital:

Primary Outcome Measures:
  • Adolescent-reported sexual activity and condom use [ Time Frame: 3 month post-intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Adolescent substance use (self-report and urine toxicology screen results) [ Time Frame: 3 months post-intervention ] [ Designated as safety issue: No ]

Enrollment: 95
Study Start Date: September 2004
Study Completion Date: October 2007
Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1 Behavioral: Affect Management
5 session group intervention that focused on teaching affect management skills and included HIV prevention and sexual health training
Active Comparator: 2 Behavioral: General Health Promotion
5 session group focused on delivering general health promotion information in didactic format

  Eligibility

Ages Eligible for Study:   13 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adolescents enrolled in the juvenile drug court program

Exclusion Criteria:

  • Adolescent is HIV positive
  • Adolescent is pregnant
  • Adolescent is developmentally delayed
  • Adolescent has history of sexual crime
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00748800

Locations
United States, Rhode Island
Rhode Island Hospital
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Rhode Island Hospital
Investigators
Principal Investigator: Larry K Brown, MD Rhode Island Hospital
  More Information

No publications provided

Responsible Party: Larry K. Brown, M.D./Principal Investigator, Rhode Island Hospital
ClinicalTrials.gov Identifier: NCT00748800     History of Changes
Other Study ID Numbers: R21 DA019245
Study First Received: September 5, 2008
Last Updated: February 5, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Rhode Island Hospital:
HIV prevention
HIV seronegativity

Additional relevant MeSH terms:
Acquired Immunodeficiency Syndrome
HIV Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
RNA Virus Infections
Retroviridae Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases

ClinicalTrials.gov processed this record on November 27, 2014